One Year Trial Evaluating Safety of Ozurdex With Eylea

Clinical trial NCT03984110 · COMPLETED

Trial details

NCT number: NCT03984110
Sponsor: Texas Retina Associates
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2019-06-11
Primary completion: 2022-10-27
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.